CYTRX CORP 4
4 · CYTRX CORP · Filed Dec 11, 2013
Insider Transaction Report
Form 4
CYTRX CORPCYTR
Wieland Douglas Scott
Sr. VP - Drug Development
Transactions
- Award
Stock Option (right to buy)
2013-12-10+150,000→ 150,000 totalExercise: $2.39Exp: 2023-12-09→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Stock Option vests monthly for 36 months beginning January 10, 2014, provided Reporting Person remains in continuous employ of Issuer.